Entrada Therapeutics Inc

NAS:TRDA (USA)  
$ 14.17 -0.18 (-1.25%) 04:00 PM EST
At Loss
P/B:
1.95
Market Cap:
$ 476.13M
Enterprise V:
$ 199.78M
Volume:
105.31K
Avg Vol (2M):
76.01K
Volume:
105.31K
At Loss
Avg Vol (2M):
76.01K

Business Description

Description
Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.
Name Current Vs Industry Vs History
Cash-To-Debt 5.16
Equity-to-Asset 0.52
Debt-to-Equity 0.28
Debt-to-EBITDA -212.56
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 1.6
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate 80.2
3-Year EPS without NRI Growth Rate 46.3

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 77.03
9-Day RSI 66.37
14-Day RSI 59.33
6-1 Month Momentum % -11.94
12-1 Month Momentum % -8.7

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.33
Quick Ratio 2.33
Cash Ratio 2.22

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -17.8
Shareholder Yield % -9.74

Financials (Next Earnings Date:2024-05-10 Est.)

TRDA's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:TRDA

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Entrada Therapeutics Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 129.013
EPS (TTM) ($) -0.26
Beta 0
Volatility % 55.26
14-Day RSI 59.33
14-Day ATR ($) 0.867638
20-Day SMA ($) 12.8775
12-1 Month Momentum % -8.7
52-Week Range ($) 10.62 - 18.44
Shares Outstanding (Mil) 33.6

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Entrada Therapeutics Inc Filings

Filing Date Document Date Form
No Filing Data

Entrada Therapeutics Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Entrada Therapeutics Inc Frequently Asked Questions

What is Entrada Therapeutics Inc(TRDA)'s stock price today?
The current price of TRDA is $14.17. The 52 week high of TRDA is $18.44 and 52 week low is $10.62.
When is next earnings date of Entrada Therapeutics Inc(TRDA)?
The next earnings date of Entrada Therapeutics Inc(TRDA) is 2024-05-10 Est..
Does Entrada Therapeutics Inc(TRDA) pay dividends? If so, how much?
Entrada Therapeutics Inc(TRDA) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1